Hoshino A, Kim HSang, Bojmar L, Gyan KEnnu, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S et al..
2020.
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.. Cell. 182(4):1044-1061.e18.
Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, Tang X, Zhu J, Zhao Z, Jaffré F et al..
2020.
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.. Cell Stem Cell. 27(1):125-136.e7.
Heras AF, Veerappan A, Silver RB, Emala CW, Worgall TS, Perez-Zoghbi J, Worgall S.
2020.
Increasing Sphingolipid Synthesis Alleviates Airway Hyperreactivity.. Am J Respir Cell Mol Biol.
Sanidad KZ, Zeng MY.
2020.
LOS in The Dysbiotic Gut.. Cell Host Microbe. 27(1):11-13.
Subrahmanyam PB, Holmes TH, Lin D, Su LF, Obermoser G, Banchereau J, Pascual V, García-Sastre A, Albrecht RA, Palucka K et al..
2020.
Mass Cytometry Defines Virus-Specific CD4 T Cells in Influenza Vaccination.. Immunohorizons. 4(12):774-788.
Sanidad KZ, Zeng MY.
2020.
Neonatal gut microbiome and immunity.. Curr Opin Microbiol. 56:30-37.
Zimmer AS, Steinberg SM, Smart DDee, Gilbert MR, Armstrong TS, Burton E, Houston N, Biassou N, Gril B, Brastianos PK et al..
2020.
Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases.. Future Oncol. 16(14):899-909.
James JA, Guthridge JM, Chen H, Lu R, Bourn RL, Bean K, Munroe ME, Smith M, Chakravarty E, Baer AN et al..
2020.
Unique Sjögren's syndrome patient subsets defined by molecular features.. Rheumatology (Oxford). 59(4):860-868.